Author:
Yamamoto Koujirou,Sawada Yasufumi,Iga Tatsuji
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics
Reference57 articles.
1. R. D. N. Birtley, J. B. Roberts, B. H. Thomas, and A. Wilson. Excretion and metabolism of14C-pyridostigmine in the rate.Br. J. Pharmacol. 26:393–402 (1966).
2. M. A. Husain, J. B. Roberts, B. H. Thomas, and A. Wilson. The excretion and metabolism of oral14C-pyridostigmine in the rat.Br. J. Pharmacol. 34:445–450 (1968).
3. T. Taylor, D. R. Hawkins, T. J. Forrest, and H. Chung. Pharmacokinetics of pyridostigmine in dogs.J. Pharm. Sci. 80:353–356 (1991).
4. T. N. Calvey and K. Chan. Plasma pyridostigmine levels in patients with myasthenia gravis.Clin. Pharmacol. Ther. 21:187–193 (1977).
5. M. C. White, P. D. Silva, and C. W. H. Havard. Plasma pyridostigmine levels in myasthenia gravis.Neurology 31:145–150 (1981).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献